Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 257,400 shares, a drop of 19.1% from the September 30th total of 318,100 shares. Based on an average trading volume of 105,800 shares, the short-interest ratio is currently 2.4 days. Approximately 4.8% of the company’s stock are sold short.
Insider Activity at Bullfrog AI
In related news, CEO Vininder Singh sold 14,405 shares of Bullfrog AI stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $2.65, for a total transaction of $38,173.25. Following the completion of the transaction, the chief executive officer now directly owns 2,478,041 shares of the company’s stock, valued at $6,566,808.65. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders sold a total of 31,603 shares of company stock valued at $82,989 in the last three months. Company insiders own 33.90% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the company. XTX Topco Ltd purchased a new position in Bullfrog AI in the second quarter worth about $32,000. Renaissance Technologies LLC bought a new stake in shares of Bullfrog AI in the second quarter worth approximately $34,000. Finally, Fortem Financial Group LLC bought a new stake in shares of Bullfrog AI in the first quarter worth approximately $171,000. 0.96% of the stock is owned by hedge funds and other institutional investors.
Bullfrog AI Stock Up 4.3 %
Bullfrog AI (NASDAQ:BFRG – Get Free Report) last issued its earnings results on Wednesday, August 7th. The company reported ($0.20) earnings per share (EPS) for the quarter.
About Bullfrog AI
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Featured Articles
- Five stocks we like better than Bullfrog AI
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 Oil Stocks to Watch Before Earnings Come Out
- Insider Trading – What You Need to Know
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.